SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-102576
Filing Date
2016-05-16
Accepted
2016-05-16 16:10:42
Documents
46
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v439231_10q.htm 10-Q 466595
2 EXHIBIT 31.1 v439231_ex31-1.htm EX-31.1 8955
3 EXHIBIT 32.1 v439231_ex32-1.htm EX-32.1 5069
  Complete submission text file 0001144204-16-102576.txt   2898123

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rgrx-20160331.xml EX-101.INS 641913
5 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20160331.xsd EX-101.SCH 29162
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20160331_cal.xml EX-101.CAL 18777
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20160331_def.xml EX-101.DEF 150287
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20160331_lab.xml EX-101.LAB 185941
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20160331_pre.xml EX-101.PRE 177868
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 161653836
SIC: 2834 Pharmaceutical Preparations